This is a bizarre critique Kurt. The company has never suggested it would take a cholesterol drug through stage 3 trials, but rather as an early drug development company. Their main misstep was doing some business in China which led to delays during Covid but they've managed their capital and this announcement is progress consistent with recent updates.
I'm confused why this wasn't deeme price sensitive
This is a bizarre critique Kurt. The company has never suggested...
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.4¢ |
Change
0.001(1.37%) |
Mkt cap ! $13.27M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 8.3¢ | 7.3¢ | $60.72K | 782.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 79991 | 7.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 70000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
7.5¢ |
Change
0.001 ( 2.74 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.9¢ | 7.3¢ | 561583 | ||
| Last updated 15.27pm 04/06/2024 ? | |||||
| NYR (ASX) Chart |